Literature DB >> 19455907

What's in a label? Ecstasy sellers' perceptions of pill brands.

Micheline Duterte1, Camille Jacinto, Paloma Sales, Sheigla Murphy.   

Abstract

This article presents selected findings from a qualitative study of Ecstasy sellers and their sales practices, knowledge of distribution networks, buyer-seller relationships, and self-reported drug use. In-depth interviews were conducted with 80 men and women who had sold five or more hits of Ecstasy five or more times in the six months prior to the interview. Study participants described their perceptions of the various types of Ecstasy they had distributed or used themselves. The participants had experience with a variety of Ecstasy labels, from the popular "Blue Dolphin" tablets to the powdered form called "Molly." We tracked pill brand mentions on Ecstasy-related websites to compare with interviewees' descriptions of Ecstasy brands. This study examines Ecstasy sellers' ideas about the role of brand names in Ecstasy markets and their relationship to their beliefs about different types of Ecstasy's purity and quality. We demonstrate that considering Ecstasy branding increases our understanding of buyer and seller relationships.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19455907      PMCID: PMC2717897          DOI: 10.1080/02791072.2009.10400672

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  14 in total

Review 1.  Ten years of 'ecstasy'.

Authors:  C M Milroy
Journal:  J R Soc Med       Date:  1999-02       Impact factor: 5.344

2.  Importance of cyberspace for the assessment of the drug abuse market: preliminary results from the Psychonaut 2002 project.

Authors:  Fabrizio Schifano; Mauro Leoni; Giovanni Martinotti; Salman Rawaf; Francesco Rovetto
Journal:  Cyberpsychol Behav       Date:  2003-08

Review 3.  Ecstasy: pharmacology and neurotoxicity.

Authors:  Jenny Morton
Journal:  Curr Opin Pharmacol       Date:  2005-02       Impact factor: 5.547

4.  An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students.

Authors:  Kira B Levy; Kevin E O'Grady; Eric D Wish; Amelia M Arria
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

Review 5.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 6.  Amphetamine designer drugs - an overview and epidemiology.

Authors:  A S Christophersen
Journal:  Toxicol Lett       Date:  2000-03-15       Impact factor: 4.372

7.  Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users.

Authors:  Russel S Falck; Robert G Carlson; Jichuan Wang; Harvey A Siegal
Journal:  Drug Alcohol Depend       Date:  2004-04-09       Impact factor: 4.492

Review 8.  The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA).

Authors:  Jon C Cole; Harry R Sumnall
Journal:  Neurosci Biobehav Rev       Date:  2003-05       Impact factor: 8.989

Review 9.  Negative experiences on Ecstasy: the role of drug, set and setting.

Authors:  Karen McElrath; Kieran McEvoy
Journal:  J Psychoactive Drugs       Date:  2002 Apr-Jun

Review 10.  Designer drugs: how dangerous are they?

Authors:  L Reneman
Journal:  J Neural Transm Suppl       Date:  2003
View more
  7 in total

Review 1.  The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.

Authors:  Philip Kamilar-Britt; Gillinder Bedi
Journal:  Neurosci Biobehav Rev       Date:  2015-09-25       Impact factor: 8.989

2.  Prevalence of reagent test-kit use and perceptions of purity among ecstasy users in an electronic dance music scene in New York City.

Authors:  Joseph J Palamar; Monica J Barratt
Journal:  Drug Alcohol Rev       Date:  2018-12-21

3.  An examination of sociodemographic correlates of ecstasy use among high school seniors in the United States.

Authors:  Joseph J Palamar; Dimitra Kamboukos
Journal:  Subst Use Misuse       Date:  2014-06-23       Impact factor: 2.164

4.  There's something about Molly: The underresearched yet popular powder form of ecstasy in the United States.

Authors:  Joseph J Palamar
Journal:  Subst Abus       Date:  2016-12-07       Impact factor: 3.716

5.  What's in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA.

Authors:  Joseph J Palamar
Journal:  J Psychoactive Drugs       Date:  2017-09-22

6.  The long tail of a demon drug: The 'bath salts' risk environment.

Authors:  Luther Elliott; Ellen Benoit; Stephanie Campos; Eloise Dunlap
Journal:  Int J Drug Policy       Date:  2017-12-15

7.  Molly users versus nonusers in a sample of college alcohol drinkers: Differences in substance-related harms and sensation seeking.

Authors:  Ashley N Linden-Carmichael; Amy L Stamates; Brynn E Sheehan; Cathy Lau-Barraco
Journal:  Subst Abus       Date:  2016-01-28       Impact factor: 3.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.